LAMBERTI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.131
AS - Asia 264
EU - Europa 248
Totale 1.643
Nazione #
US - Stati Uniti d'America 1.130
CN - Cina 121
UA - Ucraina 72
IT - Italia 58
TR - Turchia 51
SG - Singapore 49
DE - Germania 36
GB - Regno Unito 34
HK - Hong Kong 33
FI - Finlandia 22
SE - Svezia 9
CZ - Repubblica Ceca 7
ID - Indonesia 6
RU - Federazione Russa 5
IN - India 3
BE - Belgio 2
AL - Albania 1
CA - Canada 1
FR - Francia 1
KR - Corea 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.643
Città #
Fairfield 129
Woodbridge 125
Chandler 102
Ashburn 99
Houston 88
Jacksonville 81
Ann Arbor 71
Seattle 56
Wilmington 55
Cambridge 44
Singapore 39
Hong Kong 32
Beijing 30
Izmir 25
Nanjing 19
Princeton 19
Ferrara 14
Boardman 13
San Diego 12
Shanghai 10
Addison 9
Los Angeles 9
Milan 9
Nanchang 9
Tianjin 9
Washington 9
Hebei 8
Shenyang 7
Bremen 6
Helsinki 6
Jakarta 6
Jiaxing 6
Brno 5
Santa Clara 5
Zhengzhou 5
Auburn Hills 4
Norwalk 4
Campitello 3
Dearborn 3
Ningbo 3
San Mateo 3
Brussels 2
Changsha 2
Chicago 2
Kilburn 2
Kunming 2
Moscow 2
Mountain View 2
New Delhi 2
Olomouc 2
Palermo 2
Albuquerque 1
Bologna 1
Bratislava 1
Brescia 1
Central 1
Changchun 1
Clearwater 1
Falls Church 1
Hangzhou 1
Ilsan 1
Indiana 1
Jinan 1
Konya 1
Lanzhou 1
Latina 1
London 1
Marano 1
Miami Beach 1
Munich 1
Naples 1
North Charleston 1
Orange 1
Philadelphia 1
Pune 1
Redwood City 1
Rome 1
San Francisco 1
San Giorgio Ionico 1
Stienta 1
Taiyuan 1
Toronto 1
Verona 1
Totale 1.243
Nome #
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 118
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 118
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 110
null 107
null 103
null 99
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 96
null 96
null 92
Carbonic anhydrase inhibitor topical application and optic nerve head blood supply in primary open-angle glaucoma patients 80
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 78
Effects of 0.005% latanoprost and 0.5% timolol on circadian intraocular pressure variations in patients with normal tension glaucoma 73
Le manifestazioni oculari nelle malattie infiammatorie dell'intestino. 69
Effect of hinged lamellar keratotomy on postkeratoplasty eyes 67
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 62
La correzione chirurgica corneale della miopia. 57
null 54
Intraoperative cauterization of the cornea can reduce postkeratoplasty refractive error in patients with keratoconus 49
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma 29
BILATERAL CIRCUMSCRIBED HAEMANGIOMA OF THE CHOROID NOT ASSOCIATED WITH SYSTEMIC VASCULAR SYNDROME. 28
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. 23
Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. 23
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 21
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 18
Totale 1.670
Categoria #
all - tutte 7.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 304
Totale 7.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020260 0 0 0 49 21 35 26 33 28 42 21 5
2020/2021201 22 14 16 25 8 24 4 26 5 25 22 10
2021/2022203 8 16 11 7 7 4 11 9 3 14 20 93
2022/2023205 18 26 12 31 34 18 6 15 31 1 8 5
2023/2024184 12 29 11 2 44 28 4 6 7 1 2 38
2024/202570 9 11 49 1 0 0 0 0 0 0 0 0
Totale 1.670